$7M MBO Pivot to $4M ARR: Building an Acquirer-Ready Healthcare Venture

When a founder faced financing gaps and board resistance during a $7M Management Buyout (MBO) attempt, Metro provided a "Buy-or-Build" diagnostic. We determined that the legacy baggage of the target firm outweighed the benefits. Metro guided the founder to pivot and launch a lean, competitive startup instead. Our advisory covered team assembly (recruiting key ops and sales talent via equity-heavy structures) and a 6-month execution roadmap. By focusing on high-velocity closing and low capital expenditure, we turned an MBO setback into a high-growth, acquirer-magnet entity.